# Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression

> **NCT02675556** · PHASE1 · TERMINATED · sponsor: **Joshua M Hare** · enrollment: 1 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Allo-hMSCs
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02675556
- **Lead sponsor:** Joshua M Hare
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-31
- **Primary completion:** 2019-03-26
- **Final completion:** 2019-03-26
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty in recruitment and funding.
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675556, "Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02675556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*